Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413356 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Evgeny L Gulyak und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia. Hauptthemen laut MEDLINE: Immunoconjugates, Trastuzumab. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Homogeneous antibody–drug conjugates (ADCs) exhibit significantly improved pharmacological properties compared to their heterogeneous counterparts. Site-specific conjugation of the payload to the IgG required for homogeneity can be achieved using enzymes. One example is microbial transglutaminase (MTGase), which can selectively perform transamidation on the Q295 residue of human Fc when N297 glycans are removed. As a result, two modifications can be introduced per IgG molecule; however, achieving higher drug-to-antibody ratios (DARs) requires the use of branched linkers. While several such linkers have been reported, little information is available on the relationship between linker structure and ADC properties. To address this gap, we synthesized two branched amino triazide linkers, differing by a PEG4 fragment inserted after the branching point, which were used to prepare two homogeneous trastuzumab-based DAR 6 ADCs (a “short” and a “long” one). This was achieved by a two-step process consisting of enzymatic linker conjugation followed by bioorthogonal coupling with a cleavable linker bearing monomethyl auristatin E (MMAE). Two other trastuzumab–MMAE conjugates were used as controls: a heterogeneous DAR 6 ADC, made using conventional thiol–maleimide chemistry, and a homogeneous DAR 2 ADC. We found that, while the four conjugates had identical affinity for HER2, their cytotoxicity differed significantly: the “long” homogeneous DAR 6 ADC was just as active as its heterogeneous counterpart, but the “short” DAR 6 ADC was an order of magnitude less potent, inferior even to the DAR 2 conjugate. Our findings indicate that the length of the branched linker critically affects the cytotoxic activity of ADCs, possibly due to steric hindrance influencing the rate of linker cleavage by lysosomal enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia.
- Higher Chemical College of the Russian Academy of Sciences, D. Mendeleev University of Chemical Technology of Russia, Miusskaya Square 9, 125047 Moscow, Russia.
ORCID-Profile: Evgeny L Gulyak, Yury A Prokopenko, Aigul R Ibragimova, Yuliana A Mokrushina, Oxana V Serova, Mikhail Y Zhitlov, Vladimir A Brylev, Alexey V Ustinov, Vera A Alferova, Vladimir A Korshun, Ivan V Smirnov, Stanislav S Terekhov, Ksenia A Sapozhnikova
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Gulyak, E. L., Komarova, O. A., Prokopenko, Y. A., Faizullina, E. A., Malabuiok, D. M., Ibragimova, A. R., Mokrushina, Y. A., Serova, O. V., Popova, G. P., Zhitlov, M. Y., Nikitin, T. D., Brylev, V. A., Ustinov, A. V., Alferova, V. A., Korshun, V. A., Smirnov, I. V., Terekhov, S. S., & Sapozhnikova, K. A. (2024). Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413356
Vancouver
Gulyak EL, Komarova OA, Prokopenko YA, Faizullina EA, Malabuiok DM, Ibragimova AR, et al. Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413356
BibTeX
@article{Gulyak2024,
author = {Gulyak, Evgeny L and Komarova, Olga A and Prokopenko, Yury A and Faizullina, Elina A and Malabuiok, Diana M and Ibragimova, Aigul R and Mokrushina, Yuliana A and Serova, Oxana V and Popova, Galina P and Zhitlov, Mikhail Y and Nikitin, Timofei D and Brylev, Vladimir A and Ustinov, Alexey V and Alferova, Vera A and Korshun, Vladimir A and Smirnov, Ivan V and Terekhov, Stanislav S and Sapozhnikova, Ksenia A},
title = {Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413356}
}
EUVIMED